NCT07287098 2026-03-16
preEMBER
Eli Lilly and Company
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT06979596 2026-03-06
OMAHA-015
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT04059484 2026-02-24
AMEERA-3
Sanofi
Phase 2 Terminated
NCT02747004 2026-02-06
Next MONARCH 1
Eli Lilly and Company
Phase 2 Active not recruiting
NCT03272477 2024-04-17
TP-II
Palleos Healthcare GmbH
Phase 2 Completed
NCT02970682 2019-07-12
STEM
Evgen Pharma
Phase 2 Completed
NCT03879174 2019-03-18
Pembro
Mediclinic Middle East
Phase 2 Unknown
NCT01685255 2019-03-11
A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Incyte Corporation
Phase 2 Terminated
NCT00728949 2018-06-06
A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
Eli Lilly and Company
Phase 2 Completed
NCT00229697 2015-10-05
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
AstraZeneca
Phase 2 Completed
NCT00287534 2009-06-09
ARNO-95
AstraZeneca
Phase 2 Completed